Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glucose homeostasis requires the coordinated actions of various organs and is critically dependent on the proper functioning of the various cell types present in the pancreatic Langerhans islets. Here we report that chromatin architectural protein
HMGN3
is highly expressed in all pancreatic endocrine islet cells, and that Hmgn3-/- mice which have a mild diabetic phenotype, have reduced
glucagon
levels in their blood. To elucidate the mechanism leading to altered
glucagon
secretion of Hmgn3-/- mice, we tested whether
HMGN3
affect
glucagon
synthesis and secretion in alphaTC1-9 cells, a
glucagon
secreting cell line that is used to study pancreatic alpha-cell function. We find that in these cells deletion of either
HMGN3
or other HMGN variants, does not significantly affect
glucagon
gene expression or
glucagon
secretion. Our studies demonstrate a link between
HMGN3
and
glucagon
blood levels that is not directly dependent of the function of pancreatic alpha-cells.
...
PMID:The nucleosome binding protein HMGN3 is expressed in pancreatic alpha-cells and affects plasma glucagon levels in mice. 1988 67